Your session is about to expire
← Back to Search
Breathing Exercises + Meditation for Glaucoma
N/A
Waitlist Available
Research Sponsored by London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Having no significant self-reported or physician-diagnosed mental health disorder
Patients diagnosed with glaucoma
Must not have
Having acutely unstable medical illnesses, including delirium or acute cerebrovascular or cardiovascular events within the last 6 months
Having a lifetime diagnosis of self-reported other serious mental disorders, including bipolar I or II disorder, primary psychotic disorder (schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline visit, week 1, week 3, week 6, week 12
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to assess the feasibility of using breathing exercises and meditation to improve quality of life for people with glaucoma, the leading cause of irreversible blindness.
Who is the study for?
This trial is for glaucoma patients aged 40-65 who can consent, read English, sit comfortably for over half an hour, and have good hearing. They should be in stable physical health without serious mental disorders or recent substance abuse. Those with severe depression or unstable medical conditions are excluded.
What is being tested?
The study tests if breathing exercises followed by meditation can improve life quality in glaucoma patients. Participants will either do these exercises or receive usual care and then answer online questionnaires about their well-being after 12 weeks.
What are the potential side effects?
Since the intervention involves non-invasive practices like breathing exercises and meditation, significant side effects are not anticipated. However, some individuals might experience discomfort sitting still or mild stress during meditation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I do not have a significant mental health disorder.
Select...
I have been diagnosed with glaucoma.
Select...
I am between 40 and 65 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have not had a stroke, heart attack, or severe confusion in the last 6 months.
Select...
I have been diagnosed with a serious mental disorder like bipolar or schizophrenia.
Select...
I cannot see well enough to fill out questionnaires.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline visit, week 1, week 3, week 6, week 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline visit, week 1, week 3, week 6, week 12
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Anxiety
Change in Depression
Change in Sleep quality
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Breathing Exercises followed by MeditationExperimental Treatment1 Intervention
Breathing exercises and Meditation taught by Prasanna Wellness, a non-profit organization, helps dissolve stress and create a proper system in the mind. These breathing exercises include slow deep breaths and rapid breaths and are followed by meditation. Participants will receive three weekly online instructions (90 minutes each) by trained instructors in addition to standard care. Weekly 60 minutes follow-ups will include 10 minutes of breathing exercises followed by 33 minutes of guided meditation practice, and then focus on participants' experiences with breathing exercise followed by meditation during the week, additional observations, and a review of relevant knowledge to support their home practice.
Group II: No InterventionActive Control1 Intervention
The usual standard of care for patients with glaucoma includes starting them on first line of drugs. Participants will be initiated and maintained on appropriate dosages of such medications as part of standard of care. The usual standard of care also includes an ophthalmic examination measuring best-corrected Snellen VA and pinhole acuities and a follow-up visit once a year.
Find a Location
Who is running the clinical trial?
London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph'sLead Sponsor
611 Previous Clinical Trials
405,110 Total Patients Enrolled
5 Trials studying Glaucoma
498 Patients Enrolled for Glaucoma
Lawson Health Research InstituteLead Sponsor
683 Previous Clinical Trials
431,370 Total Patients Enrolled
6 Trials studying Glaucoma
558 Patients Enrolled for Glaucoma
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have not had a stroke, heart attack, or severe confusion in the last 6 months.I do not have a significant mental health disorder.You have already taken part in a study that used similar methods.I have been diagnosed with glaucoma.I have been diagnosed with a serious mental disorder like bipolar or schizophrenia.You have very severe depression, confirmed by a CES-D score of 24 or higher.You have used drugs or alcohol excessively in the past 3 months.I cannot see well enough to fill out questionnaires.I am between 40 and 65 years old.I can sit comfortably for over 30 minutes, hear well, and am in good health.
Research Study Groups:
This trial has the following groups:- Group 1: Breathing Exercises followed by Meditation
- Group 2: No Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.